BIOTECON Diagnostics and MERCK KGaA start worldwide marketin...(Potsdam Germany April 15 2008 / b3c news...)

Date:4/18/2008

Potsdam, Germany, April 15, 2008 / b3c newswire / - In order to enhance the worldwide launch of its innovative food safety testing systems, BIOTECON Diagnostics has formed a strategic marketing alliance with the globally operating MERCK KGaA, Darmstadt, Germany. Merck KGaA sells the foodproof® range which has been available in almost all countries of the world since January 1, 2008. More new products will be launched jointly during the year 2008.

Dr. Kornelia Berghof-Jaeger, CEO, BIOTECON Diagnostics: ”In this alliance Merck KGaA will contribute significantly through its expertise in microbiology and its excellent customer relationships. Jointly we are able to fulfill the customer needs by introducing this new technology to the food safety testing labs around the world.”

“For Merck KGaA this partnership means a consequential advancement in order to underline our leading position in specialty chemicals, especially in analytical reagents and test kits” comments Wolfgang E. Schmidt, Head of Microbiology, Hygiene and Microscopy at Merck KGaA. “Our philosophy of highest quality demands is perfectly met by the solutions offered by BIOTECON Diagnostics.”
 
The increasing use of rapid food safety testing is receiving more and more attention. The major reason for this key trend is that the food industry requires quick and accurate results. Traditional microbiological methods are relatively slow and sometimes inaccurate in comparison to innovative molecular biological techniques. Fast and reliable detection systems are therefore the method of choice. In particular, advanced real time PCR technology is increasingly being used in the rapid detection of food pathogens and spoilage microorganisms. PCR stands for polymerase chain reaction, a technique that allows a
'/>"/>

b3c newswire

0 GOOD

Page: 1 2 3
Related biology technology :

1. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
2. Strategic Diagnostics Updates Roth Conference Presentation Time
3. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
4. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
5. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
6. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
7. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
8. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
9. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
10. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
11. Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services